Last reviewed · How we verify
NCT06032611
Interest of Two Digital Devices for the Diagnosis of Neurocognitive Disorders in Elderly People With Cognitive Symptoms.
NA trial testing COGNUM_ALZVR in Age-related Cognitive Decline in 150 participants. Status unknown.
17 April 2024
Quick facts
| Lead sponsor | RIVAGES |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 150 |
| Start date | 17 April 2023 |
| Primary completion | 17 April 2024 |
| Estimated completion | 17 April 2024 |
| Sites | 2 locations across France |
Drugs / interventions tested
- COGNUM_ALZVR
Conditions studied
- Age-related Cognitive Decline — all drugs for Age-related Cognitive Decline →
- Computers, Handheld — all drugs for Computers, Handheld →
- Neurocognitive Disorders — all drugs for Neurocognitive Disorders →
Sponsor
RIVAGES
Who can join
Adults 60 to 110, any sex, with Age-related Cognitive Decline or Computers, Handheld. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare conventional clinical data collected as part of usual practice with data collected by the two digital tools to help diagnose major and minor neurocognitive disorders in elderly people consulting a memory center for cognitive complaints. The main question\[s\] it aims to answer are: * Is it possible to create a classification between the different intensities of cognitive impairment? * Is it possible to create a diagnostic tool consistent with the reference diagnosis? Participants will be asked to complete a series of cognitive and fine motor tasks, and will be given questionnaires on their lifestyle and medical history. They will be asked to wear a connected watch for 1 week. There is no comparison group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Conception and usability pilot study of a new digital cognitive screening tool on tablet: AlzVR project.
Maronnat F, Loup G, Degand J, Davesne F, et al · · 2025 · PMID 40496716 · DOI 10.1177/20552076251317352
Verify or expand the search:
- PubMed search for NCT06032611
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Age-related Cognitive Decline
Currently open trials in the same condition.
- NCT06948136 — Acute Effects of THC in Older Adult · Phase 1 · recruiting
- NCT06964399 — The Effect of Reminiscence Therapy in Elderly · NA · recruiting
- NCT06893432 — Cognitive Function and EEG Brain Network Remodeling Among Users of Hearing Aids With ARHL · active not recruiting
- NCT06377254 — Multi-organ Responses to CHronic Physical Activity and INactivity · NA · recruiting
- NCT04184375 — Cognitive Stimulation for Elderly Bipolar Patients · NA · recruiting
Other RIVAGES trials
Trials by the same sponsor.
- NCT06004557 — Validation of a Digital Multidimensional Assessment Tool for the Elderly in Geriatric Consultations · unknown
- NCT06047522 — Benefit of Virtual Reality Headset Use on Apathy in Older Adults With Major Neurocognitive Disorders · NA · unknown
- NCT04903171 — Effects of Enriched Gardens in Nursing Home Residents With Dementia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06032611 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RIVAGES
- Last refreshed: 13 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06032611.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing